Category Archives: Deals & Acquisitions

About deals & strategic alliances between pharmaceutical companies and new life sciences companies or biotechnology companies

Roche has obtained a licence for a biomarker from Qiagen

Posted on July 13, 2010 by Kenneth

Roche has linked up with Qiagen from the Netherlands to develop tests for a key cancer biomarker. The large company from Switzerland  has obtained a worldwide co-exclusive licence for the biomarker PI3K (phosphoinositide 3-kinase) from Qiagen to develop diagnostic assays.

Posted in Deals & Acquisitions | Leave a comment

Sanofi-Aventis buys TargeGen for a total of $560 million

Posted on June 30, 2010 by Kenneth

Sanofi-Aventis has this morning revealed it has agreed to purchase privately-held TargeGen Inc. to add treatments for certain forms of leukemia and blood disorders. Sanofi will pay $75 million as an upfront-payment to TargeGen, which is developing small molecule kinase inhibitors … Continue reading →

Posted in Deals & Acquisitions | 1 Comment